Summary
Nurix Therapeutics, Inc
Founded in 1998
Description
Nurix Therapeutics is a biotechnology company that is leading the field of protein modulation. Their innovative pipeline focuses on addressing the unmet needs of cancer patients by empowering the body to fight disease using small molecule drugs to acti...
Strengths
- Nurix Therapeutics, Inc has a strong market share in their industry
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Nurix Therapeutics, Inc was founded, the company has grown faster than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
- Variance of revenue growth is more than the industry average
Annual Revenue
Nurix Therapeutics, Inc's annual revenue
$39240000
Based on Kona Equity data
-
Revenue per employee
$132121
-
Variance of revenue growth
0.37
-
Annual revenue growth since founding
$1509231
-
Revenue growth rate from first known quarter to current
140.8%
Employee Count
297 employees
-
Employee growth rate from first known quarter to current
264.9%
Executives
Christopher Karim
Research Principal & Discovery Biology Associate
c**@nurixtx.comEren Demirhan
Vice President Head of Biometrics
e**@nurixtx.comBrandi Sails-Duru
Director, Biosample Management
b**@nurixtx.comEmily Low
Scientist I
e**@nurixtx.comGwenn Hansen
Chief Scientific Officer
g**@nurixtx.comMbole Ekaney
Biosample Manager
m**@nurixtx.comPhoebe Kenney
Director, Clinical Data Management
p**@nurixtx.comJesus Avalos
Laboratory Operations Specialist
j**@nurixtx.comEna Wang
Vice President, Cell Therapy
e**@nurixtx.comRaf Lambrecht
Vice President Head of Regulatory Affairs
r**@nurixtx.comMichael Lotze
Chief Cellular Therapy Officer
m**@nurixtx.comCristiana Guiducci
Senior VP, Immunology & Oncology Research
c**@nurixtx.comSu Kim
Vice President
s**@nurixtx.comBill Sonnenburg
Associate Director, Drug Discovery
b**@nurixtx.comChristopher Capacillo
Laboratory Technician
c**@nurixtx.comHans Vanhoute
Chief Financial Officer
h**@nurixtx.comDaniel Medina-Cleghorn
Scientist
d**@nurixtx.comEric Schlezinger
Chief People Officer
e**@nurixtx.comArthur Sands
CEO
a**@nurixtx.comJanine Powers
Vice President and Head Translational Medicine
j**@nurixtx.comBev Benson
Vice President and Head of Clinical Science
b**@nurixtx.comJohn Buell
Senior Research Associate
j**@nurixtx.comJason Kantor
Senior VP, Finance & Investment Strategy
j**@nurixtx.comArleen Kumar
Senior Manager, Cell Therapy Logistics
a**@nurixtx.comLee Alldridge
Corporate Paralegal
l**@nurixtx.comJay Gadhiya
Senior Director, Statistical Programming
j**@nurixtx.comTrang Nguyen
Senior Clinical Trial Associate
t**@nurixtx.comChristine Ring
General Counsel
c**@nurixtx.comPhone Therapeutics
Chief Executive Officer
p**@nurixtx.comMichael Blackton
Senior VP, Cell Therapy Manufacturing
m**@nurixtx.comErin Meredith
Associate Director, Clinical Operations
e**@nurixtx.comHoward Simon
Corporate Counsel & Leadership Mentor
h**@nurixtx.comG Score - 4
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Fulcrum Therapeutics, Inc.
fulcrumtx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $17.0M
- Employees: 104
- Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.
Tcr2 Therapeutics
tcr2.com- Founded in 2017
- Location: Cambridge, MA
- Annual Revenue: $29.0M
- Employees: 137
- TCR is an immunotherapy company developing the next generation of T cell therapies for patients suffering from cancer.
Ascentage Pharma Group
ascentagepharma.com- Founded in 2009
- Location: Suzhou, Jiangsu
- Annual Revenue: $80.9M
- Employees: 238
- Ascentage Pharma is a global, clinical stage biotechnology company engaged in developing novel therapies for cancers, CHB, and senesce diseases. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange of Hong Kong Limit...
Vor Biopharma
vorbio.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $45.6M
- Employees: 135
- Engineered hematopoietic stem cells that unleash the potential of targeted therapies. Hide healthy cells, expose cancer cells.
Scholar Rock Inc
scholarrock.com- Founded in 2012
- Location: Cambridge, MA
- Annual Revenue: $47.3M
- Employees: 145
- We use our unique technology platform and insights to discover new medicines that break through barriers and find optimal solutions for those who need them.
Constellation Pharmaceuticals Inc
constellationpharma.com- Founded in 2008
- Location: Cambridge, MA
- Annual Revenue: $28.0M
- Employees: 78
- Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
Key Information
- Name: Nurix Therapeutics, Inc
- Industry: Biotechnology Company
- SIC: 2833
- NAICS: 32541; 325
See similar companies
-
By City San Francisco Small Biotechnology Company in San Francisco Mid-size Biotechnology Company in San Francisco
-
By State CA Small companies in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company
-
Firmographic data G Score of 4 Founded in 1998 SIC: 2833 NAICS: 32541 NAICS: 325 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Nurix Therapeutics, Inc's headquarters are located at 1700 Owens St., Ste. 205 205 San Francisco, CA 94158.
Nurix Therapeutics, Inc's official website is nurixtx.com
Nurix Therapeutics, Inc's annual revenue is $39.2 M.
Nurix Therapeutics, Inc's SIC: 2833
Nurix Therapeutics, Inc's NAICS: 32541; 325.
Nurix Therapeutics, Inc has 297 employees
